Results 151 to 160 of about 106,775 (245)

Potential Antiarrhythmic Mechanisms of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs). [PDF]

Drug Des Devel Ther
Li J, Fu K, Zhao J, Zou Y, Li L, Huang Q, Long L, Ou X, Lei M, Zhang C, Tan X, Chen T.   +11 more
europepmc   +1 more source

Energy-Metabolism-Enhancing Probiotics Enhance the Therapeutic Response to a Glucagon-like Peptide-1 Receptor Agonist. [PDF]

Nutrients
Kim AR, Jeon SG, Park SJ, Kim BK, Kweon MN, Jang MH, Yang BG.   +6 more
europepmc   +1 more source

Corrigendum to: The Short and Sweet on Sodium-Glucose Cotransporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure. [PDF]

US Cardiol
Batista JL, Makuvire T, Davis JD, Carbone S.   +3 more
europepmc   +1 more source

Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement [PDF]

Kariem El‐Boghdadly, Jugdeep Dhesi, Philippa Fabb, Nicholas Levy, Dileep N. Lobo, Andrew McKechnie, Омар Мустафа, Philip Newland‐Jones, Anil Patel, Dimitri J. Pournaras, Ken Clare, Ketan Dhatariya   +11 more
openalex   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists for Bile Acid Diarrhea: Emerging Evidence and Clinical Implications. [PDF]

Cureus
Omeludike EK, Nwabueze CO, Ubah N, Okeke N, Aregbesola E, Onyiaorah CR, Igbokwe MA, Gujral M, Lawal RA, Akande YF.   +9 more
europepmc   +1 more source

Orforglipron, a novel non‐peptide oral daily glucagon‐like peptide‐1 receptor agonist as an anti‐obesity medicine: A systematic review and meta‐analysis [PDF]

Deep Dutta, Lakshmi Nagendra, Beatrice Anne, M. Kumar, Meha Sharma, A B Kamrul-Hasan   +5 more
openalex   +1 more source

Glucagon-like Peptide-1 Receptor Agonists and Platelet Function: Potential Benefits Beyond Glycemic Control. [PDF]

Pharmaceuticals (Basel)
Xanthopoulou M, Evangelidis P, Poulis D, Gavriilaki E, Kotsiou N, Antza C, Kotsis V, Doxani C, Mprotsis T, Zintzaras E, Anyfanti P.   +10 more
europepmc   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 13 No. 1 [PDF]

, 1977

core   +1 more source

Heart failure with preserved ejection fraction therapy: combining sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists [PDF]

John W. Ostrominski, Scott D. Solomon, Muthiah Vaduganathan   +2 more
openalex   +1 more source

State-level variation in the use of glucagon-like peptide-1 receptor agonists for weight loss and diabetes: a real-world analysis. [PDF]

J Manag Care Spec Pharm
Do S, Christensen K, Inneh A, Peasah S, Good C.   +4 more
europepmc   +1 more source